title: The rationale of prevention of thrombosis by enhancing blood levels of single-chain urokinase-type plasminogen activator (scuPA).
authors.affiliation: Gaubius Laboratory, IVVO-TNO, Leiden, The Netherlands.
authors.forename: G
authors.initials: G
authors.lastname: Dooijewaard
authors.forename: P A
authors.initials: PA
authors.lastname: van Boheemen
authors.forename: D J
authors.initials: DJ
authors.lastname: Binnema
authors.forename: C
authors.initials: C
authors.lastname: Kluft
mesh_terms: D002318:Cardiovascular Diseases / Q000150:complications / Q000503:physiopathology; D005342:Fibrinolysis; D006801:Humans; D008954:Models, Biological; D008955:Models, Cardiovascular; D013927:Thrombosis / Q000517:prevention & control*; D010959:Tissue Plasminogen Activator / Q000097:blood; D014568:Urokinase-Type Plasminogen Activator / Q000097:blood*
chemical_list: D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator